🦠 microbiology

Novel Class B2 and C β-lactamases harboured by Pseudomonas spp. wastewater isolates

This study identifies novel class B2 and C $\beta$ -lactamase genes in environmental *Pseudomonas* spp. isolates from wastewater, demonstrating that these genes confer resistance to various $\beta$ -lactam antibiotics and highlighting the importance of monitoring environmental reservoirs for emerging antimicrobial resistance.

Original authors: Kingdon, A. D. H., Allman, E., Breen, A., D'Arcy, K., McKeown, C., Graf, F. E., Roberts, A. P.

Published 2026-02-12

📖 3 min read☕ Coffee break read

CC BY 4.0

Original authors: Kingdon, A. D. H., Allman, E., Breen, A., D'Arcy, K., McKeown, C., Graf, F. E., Roberts, A. P.

Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). ⚕️ This is an AI-generated explanation of a preprint that has not been peer-reviewed. It is not medical advice. Do not make health decisions based on this content. Read full disclaimer

The Secret Underground Arsenal: How Wastewater is Hiding New Superbug Weapons

Imagine you are a general in a great war. You’ve spent years studying your enemy’s weapons: their swords, their shields, and their cannons. You know exactly how to defend against them. But what if, while you were busy guarding the castle gates, your enemy was secretly in a dark, underground workshop, inventing entirely new types of weapons that your shields can’t stop?

That is essentially what this scientific paper is about.

The Setting: The "Underground Workshop"

Most scientists focus on "clinical pathogens"—the bacteria that are already inside hospitals, actively attacking people. They study these like soldiers on a battlefield.

However, this research team decided to look somewhere else: wastewater. They looked at untreated sewage in Liverpool, UK. Think of wastewater not just as waste, but as a massive, murky "underground workshop" where bacteria live, mingle, and experiment. Because these bacteria aren't currently fighting humans in hospitals, they aren't under much pressure, which gives them the freedom to "tinker" and evolve new survival tricks.

The Discovery: New "Master Keys"

The researchers found several bacteria from the Pseudomonas family (a group of hardy, clever bacteria) that were carrying brand-new "master keys."

In the world of bacteria, antibiotics are like high-tech locks designed to shut down a cell. To survive, bacteria develop $\beta$ -lactamases—specialized enzymes that act like "master keys" or "lockpicks." These enzymes can break the antibiotic apart before it can do any damage.

The team discovered two main types of these new "lockpicks":

The Class C Crew (The Specialized Thieves): They found three new genes (blaPFL7, 8, and 9). These are like specialized tools designed to break open specific types of "locks" (cephalosporins). While they are new, they aren't invincible yet; a common "security guard" called tazobactam was still able to stop them.
The Class B2 Specialist (The Heavy-Duty Breaker): They found an even more dangerous tool called blaPFM5. This is a "metallo- $\beta$ -lactamase," which is like a heavy-duty sledgehammer. It can break open carbapenems—which are some of our "last-resort" antibiotics (the heavy artillery we use when everything else fails). Most importantly, the usual "security guards" (inhibitors) that we use to stop these hammers didn't work at all. This sledgehammer just smashed right through.

The "Ghost" in the Machine

The researchers also did something clever: they looked through public DNA databases and realized these "weapons" were already out there, hiding in plain sight in other sequences. They aren't rare; they are just "sporadic," like ghosts moving through the digital shadows of the internet.

Why This Matters: The Warning Shot

The paper concludes with a serious warning. We shouldn't just wait for these new "weapons" to show up in a hospital ward and start killing patients before we notice them.

If we only study the bacteria that are already attacking us, we are always one step behind. By studying the "underground workshop" of wastewater, we can spot these new master keys and sledgehammers before they are picked up by the most dangerous germs and brought into our hospitals.

In short: We need to keep an eye on the sewers, because that’s where the next generation of superbug weapons is being forged.

Technical Summary: Novel Class B2 and C $\beta$ -lactamases harboured by Pseudomonas spp. wastewater isolates

Problem: The Environmental Reservoir of AMR

Antimicrobial resistance (AMR) is often studied through the lens of clinical pathogens; however, resistance mechanisms frequently emerge and circulate in environmental reservoirs long before they transition into human pathogens. There is a significant research gap regarding the diversity of resistance genes present in environmental bacteria compared to clinical isolates. Identifying these "pre-clinical" resistance genes is critical for early detection and understanding the evolutionary trajectory of antibiotic resistance.

Methodology: Surveillance and Functional Characterization

The researchers conducted a multi-step investigation focusing on non-aeruginosa Pseudomonas species isolated from untreated wastewater in Liverpool, UK:

Screening: Initial screening of wastewater isolates was performed to identify the presence of extended-spectrum $\beta$ -lactamases (ESBLs) and carbapenemases.
Genomic Analysis: A subset of three highly resistant Pseudomonas spp. isolates was selected for Whole-Genome Sequencing (WGS) to identify the genetic basis of their resistance.
Phenotypic Assays: Minimum Inhibitory Concentration (MIC) assays were conducted against various $\beta$ -lactam antibiotics to characterize the resistance profiles.
Functional Validation (Ectopic Expression): To prove the resistance was caused by the newly identified genes, the researchers performed ectopic expression of four novel genes within a susceptible Escherichia coli model.
Inhibitor Testing: The efficacy of various $\beta$ -lactamase inhibitors (including tazobactam, relebactam, vaborbactam, xeruborbactam, and captopril) was tested against the novel enzymes.

Key Contributions: Discovery of Novel Resistance Genes

The study identifies and characterizes several previously undocumented $\beta$ -lactamase genes:

Class C $\beta$ -lactamases: Three novel genes, $bla_{PFL7}$ , $bla_{PFL8}$ , and $bla_{PFL9}$ . These genes showed low homology (61–71% amino acid identity) to the closest known relative, $bla_{PFL-1}$ .
Class B2 Metallo- $\beta$ -lactamase (MBL): A novel subclass B2 gene, $bla_{PFM5}$ , which shares 88% amino acid identity with its closest match, $bla_{PFM-1}$ .

Results: Enzymatic Activity and Inhibitor Profiles

Class C Activity: The novel Class C enzymes successfully degraded the cephalosporin nitrocefin. When expressed in E. coli, they conferred resistance to piperacillin and ceftazidime. Notably, these enzymes remained susceptible to inhibition by tazobactam.
Class B2 Activity: The novel MBL ( $bla_{PFM5}$ ) conferred carbapenem resistance to E. coli. Unlike the Class C enzymes, this carbapenemase was resistant to several modern inhibitors, including relebactam, vaborbactam, xeruborbactam, and captopril, highlighting a significant clinical challenge.
Prevalence: Bioinformatic analysis of public WGS data revealed analogues of these genes with $>95\%$ nucleotide identity, indicating that these resistance mechanisms are already circulating sporadically in the environment.

Significance: Implications for Public Health

This study underscores the importance of environmental surveillance in the fight against AMR. By identifying novel Class C and B2 $\beta$ -lactamases in wastewater Pseudomonas species, the research demonstrates that the environment serves as a significant, under-monitored reservoir for resistance genes. The discovery of a carbapenemase that evades current clinical inhibitors ( $bla_{PFM5}$ ) highlights the urgent need for continued monitoring of environmental bacteria to anticipate and mitigate the emergence of new, highly resistant clinical pathogens.